AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. Yasuda K, Shimodan S, Maehara N, Hirota A, et al. J Autoimmun 2023;142:103149.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yasuda K, Shimodan S, Maehara N, Hirota A, et al. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. J Autoimmun 2023;142:103149.
PMID: 38006711